Castle Creek Arbitrage’s AEON Biopharma AEON Stock Holding History

Castle Creek Arbitrage’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,470	Closed	-$1.07M	–	385
2023 Q1	$1.07M	Sell	1,470 -1,842	-56%	-$1.34M	0.12%	142
2022 Q4	$2.4M	Sell	3,312 -232	-7%	-$166K	0.21%	132
2022 Q3	$2.51M	Hold	3,544	–	–	0.14%	203
2022 Q2	$2.5M	Hold	3,544	–	–	0.14%	205
2022 Q1	$2.5M	Hold	3,544	–	–	0.13%	214
2021 Q4	$2.48M	Hold	3,544	–	–	0.12%	216
2021 Q3	$2.48M	Hold	3,544	–	–	0.14%	177
2021 Q2	$2.46M	Buy	+3,544	New	+$2.48M	0.14%	187

Other funds holding AEON

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Castle Creek Arbitrage's AEON Position: Q2 2023 in Review

Castle Creek Arbitrage sold out of AEON Biopharma (AEON) in Q2 2023, closing a stake of 1,470 shares — an estimated $1.07M sold.

Castle Creek Arbitrage first reported a position in AEON in Q2 2021 and held it in 8 quarters. The position peaked at $2.51M in Q3 2022. 17 funds tracked by Wall St. Rank hold AEON as of Q2 2023.

Castle Creek Arbitrage reported no remaining AEON Biopharma position as of Q2 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 1,470 AEON Biopharma shares in Q2 2023, an estimated $1.07M.
Castle Creek Arbitrage first reported a position in AEON Biopharma in Q2 2021 and held it in 8 quarters.
Castle Creek Arbitrage's AEON Biopharma position peaked at $2.51M in Q3 2022.
17 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2023.

Based on Castle Creek Arbitrage's 13F filing for Q2 2023, filed 14 Aug 2023.